Ultragenyx Pharmaceutical Inc.
RARE
$39.34
$0.090.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.41% | -20.46% | 85.36% | -28.61% | 30.56% |
| Total Receivables | 29.97% | -12.17% | 7.79% | 34.85% | -6.49% |
| Inventory | 3.86% | 7.97% | 11.78% | 5.71% | 6.81% |
| Prepaid Expenses | -- | -- | -- | -- | 1.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -87.32% | 2.41% | 10.25% | 2,266.88% | 1.62% |
| Total Current Assets | 2.19% | -17.11% | 61.86% | -18.60% | 22.20% |
|
|
|||||
| Total Current Assets | 2.19% | -17.11% | 61.86% | -18.60% | 22.20% |
| Net Property, Plant & Equipment | 6.97% | -2.25% | -2.25% | -9.33% | -2.71% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 8.11% | -0.78% | 0.73% | -0.74% | 5.70% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -30.99% | 0.19% | -10.34% | 77.50% | 21.11% |
| Total Assets | -2.27% | -4.95% | 23.82% | -12.34% | 20.42% |
|
|
|||||
| Total Accounts Payable | 7.69% | -39.82% | 45.97% | -2.71% | 26.25% |
| Total Accrued Expenses | 30.24% | 19.82% | 3.55% | -24.10% | 10.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.67% | 0.88% | 5.71% | 32.59% | -0.39% |
| Total Finance Division Other Current Liabilities | -11.48% | -- | -- | -- | -- |
| Total Other Current Liabilities | -11.48% | -- | -- | -- | -- |
| Total Current Liabilities | 20.75% | 4.45% | 11.11% | -12.43% | 10.42% |
|
|
|||||
| Total Current Liabilities | 20.75% | 4.45% | 11.11% | -12.43% | 10.42% |
| Long-Term Debt | -1.19% | -1.48% | -0.77% | -1.58% | -1.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 26.99% | -8.10% | -8.00% | -8.49% | -11.52% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.07% | 2.06% | 1.61% | 5.38% | 0.87% |
| Total Liabilities | 4.78% | -0.13% | 1.65% | -4.01% | 0.76% |
|
|
|||||
| Common Stock & APIC | 1.04% | 1.11% | 11.47% | 1.00% | 11.04% |
| Retained Earnings | -3.49% | -3.62% | -3.70% | -5.04% | -3.77% |
| Treasury Stock & Other | -171.76% | 181.83% | -154.06% | -166.62% | 128.83% |
| Total Common Equity | -26.39% | -19.79% | 208.29% | -49.07% | 768.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.39% | -19.79% | 208.29% | -49.07% | 768.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 0.00% | -- | -- | -- | -- |
| Total Equity | -25.87% | -18.17% | 208.29% | -49.07% | 768.43% |
|
|
|||||
